×

Controlled release pharmaceutical compositions for prolonged effect

  • US 8,821,928 B2
  • Filed: 06/04/2008
  • Issued: 09/02/2014
  • Est. Priority Date: 06/04/2007
  • Status: Expired due to Fees
First Claim
Patent Images

1. A layered pharmaceutical composition formulated and configured to provide controlled release of an active substance, the pharmaceutical composition comprising:

  • a solid inner layer (A) comprising the active substance and an effervescent agent selected to aid release of the active substance from the solid inner layer (A);

    two outer layers (B1) and (B2) that are free of the effervescent agent, each of the two outer layers (B1) and (B2) comprising the active substance and a polymer selected from a substantially water soluble or crystalline polyglycol having a molecular weight (MW) of about 100,000 daltons or greater, or a substantially water soluble or crystalline polyglycol copolymer having a MW of about 2,000 daltons or greater, and;

    a coating (C) that is impermeable to gastrointestinal fluids, the coating (C) comprising a polymer, wherein the coating (C) forms a shell around the solid inner layer (A) and the two outer layers (B1) and (B2), the solid inner layer (A) is positioned between the two outer layers (B1) and (B2) within the coating (C), and the shell formed by the coating comprises a length extending between two open ends with each of the two open ends exposing a surface area of each of the two outer layers (B1) and (B2);

    wherein the solid inner layer (A), without the outer layers (B1) and (B2) and the coating (C), is formulated such that it disintegrates within 60 minutes when subjected to the disintegration test according to Ph. Eur.;

    wherein the release of the active substance contained in the outer layers (B1) and (B2) follows a zero order release pattern for at least 80% w/w release of the total content of the active substance in the outer layers (B1) and (B2);

    wherein the coating (C) appears as a substantially intact empty shell after the composition has been subjected to the dissolution test according to Ph. Eur.

View all claims
  • 7 Assignments
Timeline View
Assignment View
    ×
    ×